Candida biotypes in patients with oral leukoplakia and lichen planus: Candida biotypes in leukoplakia and lichen planus

Mycopathologia

Volumn 134, Issue 2, 1996, Pages 75-82

  Lipperheide, Verónica ^a   Quindós, Guillermo ^a   Jiménez, Yolanda ^b   Pontón, José ^a   Bagán Sebastián, José Vicente ^b   Aguirre, José Manuel ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Biotypes; Candida; Leukoplakia; Lichen planus

Indexed keywords

ADULT; ARTICLE; CANDIDA; CANDIDA ALBICANS; CLASSIFICATION; CLINICAL TRIAL; CULTURE MEDIUM; FEMALE; HUMAN; ISOLATION AND PURIFICATION; LEUKOPLAKIA; LICHEN PLANUS; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MOUTH; MULTICENTER STUDY;

ADULT; CANDIDA; CANDIDA ALBICANS; CULTURE MEDIA; FEMALE; HUMANS; LEUKOPLAKIA, ORAL; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; MOUTH; MYCOLOGICAL TYPING TECHNIQUES;

EID: 0030471131     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00436868     Document Type: Article

References (30)

1. Contreras I, Pontón J, Quindós G. Prevalence of Candida parapsilosis in the oral cavities of infants in Spain. Clin Infect Dis 1994; 18: 480-481.
2. Odds FC. Candida and Candidosis, 2nd ed. London: Baillière Tindall, 1988: 117-123.
3. Krogh P. The role of yeasts in oral cancer by means of endogenous nitrosation. Acta Odontol Scand 1990; 48: 85-88.
4. Jepsen A, Winther JE. Mycotic infection in oral leukoplakia. Acta Odontol Scand 1965; 25: 239-256.
5. Krogh P, Holmstrup P, Thorn JJ, Vedtofte P, Pindborg JJ. Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol 1987; 63: 48-54.
6. Cawson RA, Lehner T. Chronic hyperplastic candidiasis-candidal leukoplakia. Br J Dermatol 1968; 89: 497-503.
7. Field EA, Field JK, Martin MV. Does Candida have a role in oral epithelial neoplasia? J Med Vet Mycol 1989; 27: 277-294.
8. Lundström IMC, Anneroth GB, Holmberg K. Candida in patients with oral lichen planus. Int J Oral Surg 1984; 13: 226-238.
9. Phongpaichit S, Mackenzie DWR, Fraser C. Strain differentiation of Candida albicans by morphotyping. Epidem Infect 1987; 99: 421-428.
10. Hunter P, Fraser CMA, Mackenzie DWR. Morphotype markers of virulence in human candidal infection. J Med Microbiol 1989; 28: 85-91.
11. Quindós G, Fernández-Rodriguez M, Burgos A, Tellaetxe M, Cistema R, Pontón J. Colony morphotype on Sabouraud-Triphenyl tetrazolium agar as a simple and unexpensive method for Candida subspecies discrimination. J Clin Microbiol 1992; 30: 2748-2752.
12. Oliver AJ, Reade PC. Morphotypes of oral isolates of Candida albicans from patients infected with the human immunodeficiency virus. J Med Vet Mycol 1993; 31: 289-297.
13. Borromeo GL, McCullough MJ, Reade PC. Quantitation and morphotyping of Candida albicans from healthy mouths affected by etythematous candidosis. J Med Vet Mycol 1992; 30: 477-480.
14. Martin MV, Lamb DJ. Frequency of Candida albicans serotypes in patients with denture-induced stomatitis and normal denture wearers. J Clin Pathol 1982; 35: 888-891.
15. Hasenclever HF, Mitchell WO. Antigenic studies of Candida. I. Observations of two groups in Candida albicans. J Bacteriol 1961; 82: 570-573.
16. Hasenclever HI, Mitchell WO. Antigenic studies of Candida. III. Comparative pathogenicity of Candida albicans group A, group B and Candida stellatoidea. J Bacteriol 1961; 82: 578-581.
17. Brawner DL, Cutler JE. Oral Candida albicans isolates from non-hospitalized normal carriers, immunocompetent hospitalized patients and immunocompromised patients with or without acquired immunodeficiency syndrome. J Clin Microbiol 1989; 27: 1335-1341.
18. Auger P, Dumas C, Joly J. A study of 666 strains of Candida albicans: correlation between serotype and susceptibility to 5-fluorocytosine.J Infect Dis 1979; 135; 590-594.
19. Burgos A, Bikandi J, Fernández-Rodriguez M, Pontón J, Cistema R, Quindós G. Correlación entre los serotipos A y B de Candida albicans y su sensibilidad a anfotericina B y 5-fluorocitosina. Rev Esp Quimioter 1992; 5: 79-85.
20. McCullough MJ, Ross BC, Dwyer BD, Reade PC. Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus. Microbiology 1994; 140: 1195-1202.
21. Burford-Mason AP, Weber JCP, Willoughby JMT. Oral carriage of Candida albicans, ABO group and secretory status in healthy subjects. J Med Vet Mycol 1988; 26: 49-56.
22. McGinnis M. Laboratory Handbook of Medical Mycology. New York: Academic Press, 1980: 411-430.
23. Mackenzie DWR. Serum tube identification of Candida albicans. J Clin Pathol 1962; 15: 65-67.
24. Aguirre JM, Lipperheide V, Ribacoba L et al. Prevalence of Candida among HIV-infected Spanish patients. Second International Workshop on the Oral Manifestations of HIV Infection. Menlo Park, USA, 1993.
25. Tellaetxe Isusi M. Caracterización subespecifica de los aislamientos orales de Candida y su relación con el desarrollo de la estomatitis protética. Thesis. Bilbao, Spain: Faculty of Medicine and Odontology, Basque Country University, 1993.
26. Arendorf TM, Walker DM, Kingdom RJ, Roll JRS, Newcombe RG. Tobacco smoking and denture wearing in oral candida leukiplakia. Br Dent J 1983; 155: 340-343.
27. Budtz-Jørgensen E, Holmstrup P, Krogb P. Fluconazole in the treatment of Candida-associated denture stomatitis. Antimicrobial Agents Chemother 1988; 32: 1859-1863.
28. Walker DM, Arendorf TM. Candidal leukoplakia, chronic multifocal candidosis and median rhomboid glossitis. In: Samaranayake LP Macfarlane TW (eds), Oral Candidosis. London: Wright, 1990: 184-199.
29. Gioanni J, Mazeau C, Farges MF, Viot M, Zanghellini E, Schneider M. Sécrétion par Candida albicans de substances stimulant Ia prolifération d'une lignée cellulaire d'épithelioma malpighien de Ia cavité buccale. Bul Cancer 1991; 78: 469-471.
30. Reed MF, Scragg RM, Williams DM, Soames JV. In vivo effects of Candida albicans products on rat oral epithelium. J Oral Pathol Med 1990; 19: 326-329.